CEO: Dipal Doshi
Employees: 183
IPO: Oct 29, 2021
Prijs
€ 13,48
Verandering
▲ € 0,86
6,81%
Marktkapitalisatie
516,07M
Dagbereik
€ 12,58
€ 13,66
52-Weeksbereik
€ 4,93
€ 13,66
Volume
257.064
50D / 200D Gem.
€ 11,74
€ 8,49
Vorige Slotkoers
€ 12,62
Quick Summary
Belangrijkste Punten
Earnings declined -319,04% over the past year
Debt/Equity of 0,17 — conservative balance sheet
Negative free cash flow of -129,55M
PEG of 0,01 suggests growth is underpriced
Capital efficient — spends only 4,10% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)-87,94%
Earnings (1Y)-319,04%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-39,13%
Onder sectorgemiddelde (3,61%)
ROIC-32,77%
Net Margin-565,48%
Op. Margin-613,66%
Veiligheid
Debt / Equity
0,17
Onder sectorgemiddelde (0,23)
Current Ratio12,53
Interest Coverage0,00
Waardering
P/E Ratio
-3,59
Onder sectorgemiddelde (0,23)
Forward P/EN/A
P/B Ratio1,69
EV/EBITDAN/A
Dividend Yield0,00%
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (638 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -3,6 | 0,2 |
| P/B | 1,7 | 2,9 |
| ROE % | -39,1 | 3,6 |
| Net Margin % | -565,5 | 3,9 |
| Rev Growth 5Y % | — | 9,6 |
| D/E | 0,2 | 0,2 |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -87,94% | Revenue Growth (3Y) | -55,61% |
| Earnings Growth (1Y) | -319,04% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 25,42M | Net Income (TTM) | -143,75M |
| ROE | -39,13% | ROA | -38,09% |
| Gross Margin | 83,89% | Operating Margin | -613,66% |
| Net Margin | -565,48% | Free Cash Flow (TTM) | -129,55M |
| ROIC | -32,77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,17 | Current Ratio | 12,53 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3,59 | Forward P/E | N/A |
| P/B Ratio | 1,69 | P/S Ratio | 20,30 |
| PEG Ratio | 0,01 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -25,10% | ||
| Market Cap | 516,07M | Enterprise Value | 476,61M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 25,42M | 210,78M | 129,01M | 0,0 | 0,0 |
| Net Income | -143,75M | 65,63M | -6,69M | -94,62M | -51,16M |
| EPS (Diluted) | -3,47 | 1,68 | -0,20 | -2,79 | -1,60 |
| Gross Profit | 21,33M | 210,78M | 129,01M | 0,0 | 0,0 |
| Operating Income | -156,00M | 47,01M | -3,16M | -97,25M | -51,13M |
| EBITDA | -142,40M | 50,78M | -321.000,0 | -95,35M | -50,01M |
| R&D Expenses | 142,27M | 125,31M | 99,88M | 66,61M | 35,93M |
| SG&A Expenses | 41,05M | 38,47M | 32,29M | 30,64M | 15,20M |
| D&A | 425.000,0 | 3,77M | 2,84M | 1,90M | 1,12M |
| Interest Expense | 0,0 | 0,0 | 0,0 | 2,63M | 0,0 |
| Income Tax | 924.000,0 | 859.000,0 | 18,74M | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 377,38M | 526,32M | 469,19M | 252,06M | 305,83M |
| Total Liabilities | 71,25M | 97,64M | 226,83M | 39,50M | 7,12M |
| Shareholders' Equity | 306,13M | 428,68M | 242,36M | 212,55M | 298,72M |
| Total Debt | 50,93M | 59,21M | 68,23M | 25,94M | 0,0 |
| Cash & Equivalents | 90,39M | 101,21M | 67,60M | 45,16M | 291,06M |
| Current Assets | 306,25M | 440,04M | 369,77M | 209,88M | 298,70M |
| Current Liabilities | 24,45M | 39,48M | 158,80M | 21,97M | 6,72M |